Cargando…

Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection

Human respiratory syncytial virus (hRSV) infection is a major pediatric health concern worldwide. Despite more than half a century of efforts, there is still no commercially available vaccine. In this study, we constructed and purified the recombinant protein CTA1-DD-RBF composed of a CTA1-DD mucosa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hai, Ren, Hu, Zhang, Yan, Cao, Lei, Xu, Wenbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452643/ https://www.ncbi.nlm.nih.gov/pubmed/34545126 http://dx.doi.org/10.1038/s41598-021-97535-6

Ejemplares similares

Modulation of host adaptive immunity by hRSV proteins
por: Espinoza, Janyra A, et al.
Publicado: (2014)

Human respiratory syncytial virus (hRSV) RNA quantification in nasopharyngeal secretions identifies the hRSV etiologic role in acute respiratory tract infections of hospitalized infants
por: Campanini, Giulia, et al.
Publicado: (2007)

TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine
por: Rey-Jurado, Emma, et al.
Publicado: (2020)

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020)

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
por: Gálvez, Nicolás M. S., et al.
Publicado: (2017)

Establishment and application of a lethal model of an HRSV-long variant strain in BALB/c mice
por: LI, Hai, et al.
Publicado: (2022)

HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice
por: Li, Hai, et al.
Publicado: (2022)

Lung pathology due to hRSV infection impairs blood–brain barrier permeability enabling astrocyte infection and a long-lasting inflammation in the CNS
por: Bohmwald, Karen, et al.
Publicado: (2021)

Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis
por: Yin, Li-Tian, et al.
Publicado: (2013)

In Silico Approach towards Designing Virtual Oligopeptides for HRSV
por: Jain, Ruchi, et al.
Publicado: (2014)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
por: Endt, Kathrin, et al.
Publicado: (2022)

Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity
por: Nedrud, John G., et al.
Publicado: (2013)

Presence of ON1 and BA HRSV-genotypes in Paraguay, 2010–2013
por: Espínola, Emilio E., et al.
Publicado: (2015)

A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles
por: Rigter, Alan, et al.
Publicado: (2013)

A Candidate Therapeutic Monoclonal Antibody Inhibits Both HRSV and HMPV Replication in Mice
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2022)

Partial Protective Effect of Intranasal Immunization with Recombinant Toxoplasma gondii Rhoptry Protein 17 against Toxoplasmosis in Mice
por: Wang, Hai-Long, et al.
Publicado: (2014)

Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice
por: Liu, Zhuanzhuan, et al.
Publicado: (2016)

The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins
por: Touzelet, Olivier, et al.
Publicado: (2020)

Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice
por: Yin, Li-Tian, et al.
Publicado: (2023)

Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice
por: Maunder, Helen E., et al.
Publicado: (2015)

Retinoblastoma protein activity revealed by CRISPRi study of divergent Rbf1 and Rbf2 paralogs
por: Raicu, Ana-Maria, et al.
Publicado: (2023)

Evaluation of CTA for use at Fermilab
por: Bauer, Ren
Publicado: (2022)

The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization
por: Schussek, Sophie, et al.
Publicado: (2020)

CTA at RAL
por: Patargias, George
Publicado: (2022)

CTA at DESY
por: Karimi, Mwai
Publicado: (2023)

CTA at PIC
por: Carrasco Santos, Elisabet
Publicado: (2023)

CTA at AARNet
por: Not Supplied, Denis Lujanski
Publicado: (2022)

Fine mapping of epitopes by intradomain Kd/Dd recombinants
Publicado: (1987)

Circulation of HRSV in Belgium: From Multiple Genotype Circulation to Prolonged Circulation of Predominant Genotypes
por: Houspie, Lieselot, et al.
Publicado: (2013)

Protective Immunity against Canine Distemper Virus in Dogs Induced by Intranasal Immunization with a Recombinant Probiotic Expressing the Viral H Protein
por: Jiang, Yanping, et al.
Publicado: (2019)

CTA CI: Running a standalone CTA instance with latest kubernetes
por: Leduc, Julien
Publicado: (2023)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

An intranasal recombinant NDV-BRSV F(opt) vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection
por: Sacco, Randy E., et al.
Publicado: (2022)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children
por: Kumaria, Rajni, et al.
Publicado: (2011)

Gene Sequence Variability of the Three Surface Proteins of Human Respiratory Syncytial Virus (HRSV) in Texas
por: Tapia, Lorena I., et al.
Publicado: (2014)

Phylodynamics and Dispersal of HRSV Entails Its Permanence in the General Population in between Yearly Outbreaks in Children
por: Katzov-Eckert, Hagit, et al.
Publicado: (2012)

CTA Challenges and Roadmap
por: Davis, Michael
Publicado: (2023)

Restic CTA at AARNet
por: Lujanski, Denis Sergeevich
Publicado: (2023)

CTA efforts at Fermilab
por: Vaandering, Eric
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1g4jfcm75uulr7ala9e98cn5jl